Grace Therapeutics, Inc. (GRCE) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 18, 2026.
- Filings shown
- 20
- Open-market buys
- 25
- Open-market sells
- 0
- Buys, 10b5-1 box not checked
- 25 of 25
Counts cover the 20 most recent Form 4 filings Tradune holds for GRCE (filed Aug 19 – Nov 18, 2026); the score below covers only the trailing 90 days (24 buys, 0 sells). SEC EDGAR Form 4 filings for GRCE last checked Nov 21, 2026, 09:00 UTC; the latest GRCE filing Tradune holds was filed Nov 18, 2026. This is not guaranteed to be the complete record — see GRCE's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 19 filings Tradune holds for GRCE filed Sep 1 – Nov 18, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Opaleye Management Inc.10% owner | 23 | 0 | 342,913 | — | +$652,723 |
| Prashant KohliChief Executive Officer | 1 | 0 | 100,000 | — | +$214,000 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
78/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at GRCE
Insiders reported 25 open-market purchases of GRCE between Aug 19, 2026 and Nov 18, 2026, across 2 distinct buyers. The most recent purchase was reported by Opaleye Management Inc. (10% owner) on Nov 18, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,974 | $1.73 | 3,102,904 (indirect) | +0.1% | Nov 18, 2026 |
| Open-market purchase 10b5-1 box not checked | 29,207 | $1.72 | 3,099,930 (indirect) | +1.0% | Nov 17, 2026 |
| Open-market purchase 10b5-1 box not checked | 15,879 | $1.76 | 3,070,723 (indirect) | +0.5% | Nov 16, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 3,087 | $1.77 | 3,054,853 (indirect) | +0.1% | Nov 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 5,027 | $1.80 | 3,051,766 (indirect) | +0.2% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 10,328 | $1.79 | 3,046,739 (indirect) | +0.3% | Nov 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 66,411 | $1.77 | 3,036,411 (indirect) | +2.2% | Oct 26, 2026 |
| Open-market purchase 10b5-1 box not checked | 21,390 | $1.93 | 2,970,000 (indirect) | +0.7% | Oct 22, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 4,256 | $1.88 | 2,948,610 (indirect) | +0.1% | Oct 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 36,347 | $1.89 | 2,944,354 (indirect) | +1.2% | Oct 16, 2026 |
| Open-market purchase 10b5-1 box not checked | 23,485 | $1.95 | 2,908,007 (indirect) | +0.8% | Oct 15, 2026 |
| Open-market purchase 10b5-1 box not checked | 11,233 | $1.93 | 2,884,522 (indirect) | +0.4% | Oct 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 7,215 | $2.02 | 2,873,289 (indirect) | +0.3% | Oct 12, 2026 |
| Open-market purchase 10b5-1 box not checked | 5,340 | $2.04 | 2,866,074 (indirect) | +0.2% | Oct 9, 2026 |
| Open-market purchase 10b5-1 box not checked | 2,077 | $2.02 | 2,860,734 (indirect) | +0.1% | Oct 8, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 1,694 | $2.06 | 2,858,657 (indirect) | +0.1% | Oct 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 20,000 | $2.07 | 2,856,963 (indirect) | +0.7% | Oct 2, 2026 |
| Open-market purchase 10b5-1 box not checked | 38,796 | $2.04 | 2,836,963 (indirect) | +1.4% | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 7,849 | $2.09 | 2,798,167 (indirect) | +0.3% | Sep 29, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 5,318 | $2.10 | 2,790,318 (indirect) | +0.2% | Sep 23, 2026 |
| Open-market purchase 10b5-1 box not checked | 9,771 | $2.10 | 2,785,000 (indirect) | +0.4% | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 12,200 | — | — | — | Sep 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | — | — | — | — | Sep 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 12,200 | — | — | — | Sep 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 12,200 | — | — | — | Sep 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 5,836 | $2.09 | 2,775,229 (indirect) | +0.2% | Sep 9, 2026 |
| Open-market purchase 10b5-1 box not checked | 9,393 | $2.10 | 2,769,393 (indirect) | +0.3% | Sep 8, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 100,000 | $2.14 | 121,357 | +468% | Sep 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 267,160 | — | — | — | Aug 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 35,760 | — | — | — | Aug 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 54,690 | — | — | — | Aug 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 33,660 | — | — | — | Aug 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 11,608 | $2.09 | 2,760,000 (indirect) | +0.4% | Aug 14, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to GRCE's (Nov 18, 2026).
Frequently asked about GRCE insider activity
How many insiders bought GRCE stock in these Form 4 filings?
2 distinct insiders at Grace Therapeutics, Inc. reported 25 open-market purchases (Form 4 code P) of GRCE shares between Aug 19, 2026 and Nov 18, 2026, the most recent filed by Opaleye Management Inc. (10% owner) on Nov 18, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for GRCE?
The most recent Form 4 on this page was filed by Opaleye Management Inc. (10% owner) on Nov 18, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market GRCE insider purchase shown?
The largest open-market purchase among the filings shown was 100,000 GRCE shares at $2.14 (about $214,000) by Prashant Kohli (Chief Executive Officer) on Sep 9, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent GRCE insider purchases have the Form 4 10b5-1 box checked?
No. All 25 GRCE open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Opaleye Management Inc. (10% owner) on Nov 18, 2026, 2,974 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for GRCE — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.